2020 - ESSA Pharma

Date	Title
June 22, 2020	ESSA Pharma Presents Therapeutic Potential of EPI-7386 at the 2020 American Association for Cancer Research Virtual Annual Meeting II
May 27, 2020	ESSA Pharma to Present at Jefferies Virtual Healthcare Conference
May 15, 2020	ESSA Pharma Presents Therapeutic Potential of EPI-7386 at 2020 Virtual American Urological Association (AUA) Annual Meeting
May 7, 2020	ESSA Pharma Provides Corporate Update and Reports Financial Results for Fiscal Second Quarter Ended March 31, 2020
April 13, 2020	ESSA Pharma Enters into At-The-Market Equity Offering Sales Agreement
March 31, 2020	ESSA Pharma Submits IND for EPI-7386 for Prostate Cancer and Provides Business Update
February 27, 2020	ESSA Pharma Inc. Reports Results of Annual General & Special Meeting of Shareholders
February 14, 2020	ESSA Pharma Provides Corporate Update and Reports Financial Results for Fiscal First Quarter Ended December 21, 2019
February 10, 2020	ESSA Pharma Announces Multiple Abstracts Accepted for Presentation at Upcoming Medical and Scientific Symposia